Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Frequency Therapeutics, Inc. (FREQ)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/12/2023 |
4/A
| Mitrano Richard J. (VP Finance & Operations) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 220 shares
@ $0.36, valued at
$79.2 Sold 220 shares
@ $0.37, valued at
$81.4 |
|
07/12/2023 |
4/A
| Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 2,634 shares
@ $0.35, valued at
$921.9 Sold 2,591 shares
@ $0.38, valued at
$984.6 |
|
07/12/2023 |
4/A
| Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 1,306 shares
@ $0.36, valued at
$470.2 Sold 1,304 shares
@ $0.37, valued at
$482.5 |
|
07/12/2023 |
4/A
| Mitrano Richard J. (VP Finance & Operations) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 224 shares
@ $0.35, valued at
$78.4 Exercised 25,000 restricted stock units
@ $0 |
|
07/12/2023 |
4/A
| Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Gifted 13,345 shares
@ $0 Gifted 33,345 shares
@ $0 Sold 2,773 shares
@ $0.34, valued at
$942.8 Exercised 300,000 restricted stock units
@ $0 |
|
07/12/2023 |
4/A
| Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Sold 1,384 shares
@ $0.34, valued at
$470.6 Exercised 150,000 restricted stock units
@ $0 |
|
07/23/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|